Skip to main content
KLRS logo

KLRS

Kalaris Therapeutics, Inc.
$4.75 +0.22 (+4.86%) At close · Jul 2
Market Cap
$113.01M
Shares
23,792,278

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 58
Total Value: $107,199,483
Total Shares: 18,578,771

Institutional Ownership Trend

5 quarters

Holder Concentration

Across 58 13F filers · Δ vs Dec 31, 2025
Top Holder
69.7%
Mar 2025 → Mar 2026 · range 69.7% – 86.6%
−2.3 pts
Top 5
85.9%
Mar 2025 → Mar 2026 · range 85.9% – 95.6%
−1.8 pts
Top 10
92.2%
Mar 2025 → Mar 2026 · range 92.2% – 98.7%
−1.1 pts
HHI
4,947
Mar 2025 → Mar 2026 · range 4,947 – 7,519
Highly concentrated−318

Quarterly Activity

vs Dec 31, 2025
New
15
Increased
16
Decreased
7
Sold Out
8
Unchanged
20
Holder count: +7
Institutional value: -29.4%
Shares held: +3.2%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 58 of 58
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1754068 CUSIP 482929106 Visit website Investor relations